Get started
Author

Albert F. Candia

Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
2016 · Irma Garcia-Martinez, Nicola Santoro, et al. · Journal of Clinical Investigation · 518
PDF
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
2018 · Antoni Ribas, Theresa Medina, et al. · Cancer Discovery · 344
Mox-1 and Mox-2 define a novel homeobox gene subfamily and are differentially expressed during early mesodermal patterning in mouse embryos
1992 · Albert F. Candia, Jinxin Hu, et al. · Development · 282
Cellular interpretation of multiple TGF-β signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads
1997 · Albert F. Candia, Tetsuro Watabe, et al. · Development · 258
Molecular mechanisms of Spemann's organizer formation: conserved growth factor synergy between Xenopus and mouse.
1995 · T Watabe, S Kim, et al. · Genes & Development · 224
Mox2 is a component of the genetic hierarchy controlling limb muscle development
1999 · Baljinder S. Mankoo, Nina S. Collins, et al. · Nature · 199
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
2018 · Matthew J. Frank, Patrick M. Reagan, et al. · Cancer Discovery · 190
The murine type II TGF-β receptor has a coincident embryonic expression and binding preference for TGF-β1
1994 · Sean Lawler, Albert F. Candia, et al. · Development · 87
Small-Molecule TLR8 Antagonists via Structure-Based Rational Design
2018 · Zhenyi Hu, Hiromi Tanji, et al. · Cell chemical biology · 62
PDF
Pleiotrophin induces formation of functional neovasculature in vivo
2005 · Karen L. Christman, Qizhi Fang, et al. · Biochemical and Biophysical Research Communications · 62
Differential localization of Mox-1 and Mox-2 proteins indicates distinct roles during development
1996 · A F Candia, C V Wright · The International Journal of Developmental Biology · 49
PDF
Expression of a Homologue of the Deleted in Colorectal Cancer (DCC) Gene in the Nervous System of Developing Xenopus Embryos
1994 · William E. Pierceall, Michael A. Reale, et al. · Developmental Biology · 40
Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy.
2019 · Mohammed M. Milhem, Georgina V. Long, et al. · Journal of Clinical Oncology · 33
Phase 1b/2, open label, multicenter study of intratumoral SD-101 in combination with pembrolizumab in anti-PD-1 treatment naïve patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
2019 · Ezra E.W. Cohen, Lisle Nabell, et al. · Journal of Clinical Oncology · 30
First‐in‐Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well‐Tolerated
2017 · Sam Jackson, Albert F. Candia, et al. · Clinical Pharmacology & Therapeutics · 30
A Phase Ib Open-Label, Multicenter Study of Inhaled DV281, a TLR9 Agonist, in Combination with Nivolumab in Patients with Advanced or Metastatic Non–small Cell Lung Cancer
2021 · Edward B. Garon, Alexander I. Spira, et al. · Clinical Cancer Research · 26
The expression pattern of Xenopus Mox-2 implies a role in initial mesodermal differentiation
1995 · Albert F. Candia, Christopher V.E. Wright · Mechanisms of Development · 24
SD-101, a Novel Class C CpG-Oligodeoxynucleotide (ODN) Toll-like Receptor 9 (TLR9) Agonist, Given with Low Dose Radiation for Untreated Low Grade B-Cell Lymphoma: Interim Results of a Phase 1/2 Trial
2016 · Ronald Levy, Patrick M. Reagan, et al. · Blood · 17
Differential induction of the c‐fos promoter through distinct PDGF receptor‐mediated signaling pathways
1992 · Kevin E. Salhany, Cheryl Robinson‐Benion, et al. · Journal of Cellular Physiology · 16
Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced/metastatic melanoma resistant to anti-PD-1/PD-L1 therapy.
2019 · Asim Amin, Mohammed M. Milhem, et al. · Journal of Clinical Oncology · 12
Fetal Expression of Renin, Angiotensinogen, and Atriopeptin Genes in Chick Heart
1990 · Mitchell I. Chernin, Albert F. Candia, et al. · Clinical and Experimental Hypertension · 11
Pos1062 Therapeutic Potential of Imvotamab, a Cd20-targeted Bispecific Igm T Cell Engager, for the Treatment of Refractory Autoimmune Disease Patients
2024 · R. Domingo-Gonzalez, I. Baribaud, et al. · Annals of the Rheumatic Diseases · 10
Amino acid sequence of Mox-2 and comparison to itsXenopusand rat homologs
1993 · Albert F. Candia, Jean-Paul Kovalik, et al. · Nucleic Acids Research · 8
PDF
Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy
2018 · G.V. Long, M. Milhem, et al. · Annals of Oncology · 5
Phase 1b/2, open-label, multicenter, dose escalation and expansion trial of intratumoral SD 101 in combination with pembrolizumab in patients with metastatic melanoma
2016 · A. Ribas, R. Gonzalez, et al. · Annals of Oncology · 5
PDF
Works count: 45
Citation count: 2,555
H-index: 17
I10-index: 22
Year
Topic
Type